MRI system significantly improves prostate cancer detection and efficiency. Find out how ProAI boosts accuracy and reduces ...

In this episode, Nicolas Girard discusses the latest developments in non-small cell lung cancer (NSCLC), with a focus on new ...

Phase 3b WAYFINDER data show tezepelumab oral corticosteroid reduction in severe asthma, with nearly 90 percent reaching 5 mg ...

Over half of patients with severe asthma discontinued oral corticosteroids while maintaining disease control, major study ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

Sexually transmitted infections (STI) have a disproportionately high prevalence in individuals in custody and persons with ...

This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor ...

A simple blood test analysed by artificial intelligence could revolutionise early detection of primary vitreoretinal lymphoma ...

Standalone MRI caught most breast cancer cases missed by AI, highlighting a key safety net for dense breasts. Find out more.

Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy ...

The following highlights showcase key research presented at the European Society for Medical Oncology (ESMO) 2025 Congress.

EMJ's latest Oncology Journal is now available, covering everything you need to know from ESMO 2025 and beyond. Inside, ...